Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'P-GLYCOPROTEIN EXPRESSION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 455 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lowenberg, B
      Prognostic factors in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    2. Sonneveld, P; List, AF
      Chemotherapy resistance in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    3. Trieb, K; Kotz, R
      Proteins expressed in osteosarcoma and serum levels as prognostic factors

      INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    4. Warren, AJ; Mustra, DJ; Hamilton, JW
      Detection of mitomycin C-DNA adducts in human breast cancer cells grown inculture, as xenografted tumors in nude mice, and in biopsies of human breast cancer patient tumors as determined by P-32-postlabeling

      CLINICAL CANCER RESEARCH
    5. Baldus, C; Fietz, T; Rieder, H; Schwartz, S; Thiel, E; Knauf, W
      MDR-1 expression and deletions of chromosomes 7 and 5(Q) separately indicate adverse prognosis in AML

      LEUKEMIA & LYMPHOMA
    6. Russo, D; Pricolo, G; Michieli, M; Michelutti, A; Raspadori, D; Bertone, A; Marin, L; Pierri, I; Bucalossi, A; Zuffa, E; De Vivo, A; Mazza, P; Gobbi, M; Lauria, F; Zaccaria, A; Baccarani, M
      Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia

      LEUKEMIA & LYMPHOMA
    7. Sun, SS; Shiau, YC; Lin, CC; Kao, A; Lee, CC
      Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings

      NUCLEAR MEDICINE AND BIOLOGY
    8. Berger, F; Soligo, D; Schwarz, K; Bossolasco, P; Schrezenmeier, H; Kubanek, B; Deliliers, GL; Licht, T
      Efficient retrovirus-mediated transduction of primitive human peripheral blood progenitor cells in stroma-free suspension culture

      GENE THERAPY
    9. Aratani, T; Narabayashi, I; Komori, T; Utsunomiya, K; Sueyoshi, K; Tachibana, S; Sasaki, S
      Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression levels in non-small cell lung cancer - a preliminary report

      ANNALS OF NUCLEAR MEDICINE
    10. Lehmann, S; Bengtzen, S; Paul, A; Christensson, B; Paul, C
      Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance

      EUROPEAN JOURNAL OF HAEMATOLOGY
    11. Visani, G; Milligan, D; Leoni, F; Chang, J; Kelsey, S; Marcus, R; Powles, R; Schey, S; Covelli, A; Isidori, A; Litchman, M; Piccaluga, PP; Mayer, H; Malagola, M; Pfister, C
      Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia

      LEUKEMIA
    12. van den Heuvel-Eibrink, MM; Wiemer, EAC; de Boevere, MJ; Slater, RM; Smit, EME; van Noesel, MM; van der Holt, B; Schoester, M; Pieters, R; Sonneveld, P
      MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7

      LEUKEMIA
    13. Vanhoefer, U; Harstrick, A; Achterrath, W; Cao, SS; Seeber, S; Rustum, YM
      Irinotecan in the treatment of colorectal cancer: Clinical overview

      JOURNAL OF CLINICAL ONCOLOGY
    14. Miller, KD; Sweeney, CJ; Sledge, GW
      Redefining the target: Chemotherapeutics as antiangiogenics

      JOURNAL OF CLINICAL ONCOLOGY
    15. Gaynor, ER; Unger, JM; Miller, TP; Grogan, TM; White, LA; Mills, GM; Balcerzak, SP; Varterasian, M; LeBlanc, M; Fisher, RI
      Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: A Southwest Oncology Group study

      JOURNAL OF CLINICAL ONCOLOGY
    16. Peck, RA; Hewett, J; Harding, MW; Wang, YM; Chaturvedi, PR; Bhatnagar, A; Ziessman, H; Atkins, F; Hawkins, MJ
      Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin

      JOURNAL OF CLINICAL ONCOLOGY
    17. Maitra, R; Shaw, CM; Stanton, BA; Hamilton, JW
      Increased functional cell surface expression of CFTR and Delta F508-CFTR by the anthracycline doxorubicin

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    18. Paietta, E; Neuberg, D; Richards, S; Bennett, JM; Han, L; Racevskis, J; Dewald, G; Rowe, JM; Wiernik, PH
      Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity

      AMERICAN JOURNAL OF HEMATOLOGY
    19. Burak, Z; Ersoy, O; Moretti, JL; Erinc, R; Ozcan, Z; Dirlik, A; Sabah, D; Basdemir, G
      The role of Tc-99m-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    20. Tsai, SC; Shiau, YC; Wang, JJ; Ho, YJ; Kao, CH
      Comparison of the uptake and clearance of Tc-99m MIBI, TI-201 and Ga-67 indrug-resistant lymphoma cell lines

      CANCER LETTERS
    21. Shiau, YC; Tsai, SC; Wang, JJ; Ho, YJ; Ho, ST; Kao, CH
      Predicting chemotherapy response and comparing with P-glycoprotein expression using technetium-99m tetrofosmin scan in untreated malignant lymphomas

      CANCER LETTERS
    22. Shannon, BA; Iacopetta, BJ
      Methylation of the hMLH1, p16, and MDR1 genes in colorectal carcinoma: associations with clinicopathological features

      CANCER LETTERS
    23. Loggini, B; Rinaldi, I; Pingitore, R; Cristofani, R; Castagna, M; Barachini, P
      Immunohistochemical study of 49 cutaneous melanomas: p53, PCNA, Bcl-2 expression and multidrug resistance

      TUMORI
    24. Fardel, O; Payen, L; Courtois, A; Vernhet, L; Lecureur, V
      Regulation of biliary drug efflux pump expression by hormones and xenobiotics

      TOXICOLOGY
    25. Hirsch-Ernst, KI; Ziemann, C; Rustenbeck, I; Kahl, GF
      Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures

      TOXICOLOGY
    26. Lehmann, T; Kohler, C; Weidauer, E; Taege, C; Foth, H
      Expression of MRP1 and related transporters in human lung cells in culture

      TOXICOLOGY
    27. Ros, JE; Schuetz, JD; Geuken, M; Streetz, K; Moshage, H; Kuipers, F; Manns, MP; Jansen, PLM; Trautwein, C; Muller, M
      Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappa B signaling

      HEPATOLOGY
    28. Regina, A; Morchoisne, S; Borson, ND; McCall, AL; Drewes, LR; Roux, F
      Factor(s) released by glucose-deprived astrocytes enhance glucose transporter expression and activity in rat brain endothelial cells

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    29. Bredel, M
      Anticancer drug resistance in primary human brain tumors

      BRAIN RESEARCH REVIEWS
    30. Polk, RE; Brophy, DF; Israel, DS; Patron, R; Sadler, BM; Chittick, GE; Symonds, WT; Lou, Y; Kristoff, D; Stein, DS
      Pharmacokinetic interaction between amprenavir and rifabutin or rifampin in healthy males

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    31. van Gelder, T; Klupp, J; Sawamoto, T; Christians, U; Morris, RE
      ATP-binding cassette transporters and calcineurin inhibitors: Potential clinical implications

      TRANSPLANTATION PROCEEDINGS
    32. Kato, A; Miyazaki, M; Ambiru, S; Yoshitomi, H; Ito, H; Nakagawa, K; Shimizu, H; Yokosuka, O; Nakajima, N
      Multidrug resistance gene (MDR-1) expression as a useful prognostic factorin patients with human hepatocellular carcinoma after surgical resection

      JOURNAL OF SURGICAL ONCOLOGY
    33. Vernhet, L; Seite, MP; Allain, N; Guillouzo, A; Fardel, O
      Arsenic induces expression of the multidrug resistance-associated protein 2 (MRP2) gene in primary rat and human hepatocytes

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    34. Gibbs, CP; Weber, K; Scarborough, MT
      Malignant bone tumors

      JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
    35. Uematsu, T; Hasegawa, T; Hiraoka, BY; Komatsu, F; Matsuura, T; Yamada, AS; Yamaoka, M
      Multidrug resistance gene 1 expression in salivary gland adenocarcinomas and oral squamous-cell carcinomas

      INTERNATIONAL JOURNAL OF CANCER
    36. Zhan, MC; Yu, DH; Lang, AQ; Li, L; Pollock, RE
      Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression

      CANCER
    37. Yin, JAL; Wheatley, K; Rees, JKH; Burnett, AK
      Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial

      BRITISH JOURNAL OF HAEMATOLOGY
    38. Kao, CH; Tsai, SC; Wang, JJ; Ho, YJ; Ho, ST; Changlai, SP
      Technetium-99m-sestamethoxyisobutylisonitrile scan as a predictor of chemotherapy response in malignant lymphomas compared with P-glycoprotein expression, multidrug resistance-related protein expression and other prognosis factors

      BRITISH JOURNAL OF HAEMATOLOGY
    39. Karaszi, E; Jakab, K; Homolya, L; Szakacs, G; Hollo, Z; Telek, B; Kiss, A; Rejto, L; Nahajevszky, S; Sarkadi, B; Kappelmayer, J
      Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    40. Ichihashi, N; Kitajima, Y
      Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells

      BRITISH JOURNAL OF DERMATOLOGY
    41. List, AF; Kopecky, KJ; Willman, CL; Head, DR; Persons, DL; Slovak, ML; Dorr, R; Karanes, C; Hynes, HE; Doroshow, JH; Shurafa, M; Appelbaum, FR
      Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

      BLOOD
    42. Baer, MR; Stewart, GC; Dodge, RK; Leget, G; Sule, N; Mrozek, K; Schiffer, CA; Powel, BL; Kolitz, JE; Moore, JO; Stone, RM; Davey, FR; Carrol, AJ; Larson, RA; Bloomfield, CD
      High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

      BLOOD
    43. Chou, KM; Krapcho, AP; Hacker, MP
      Impact of the basic amine on the biological activity and intracellular distribution of an aza-anthrapyrazole: BBR 3422

      BIOCHEMICAL PHARMACOLOGY
    44. Decorti, G; Rosati, A; Candussio, L; Giraldi, T; Klugmann, FB
      Characterization of multidrug transporters in a normal renal tubular cell line resistant to doxorubicin - Multidrug transporters in the LLC-PK1 cell line and its resistant counterpart

      BIOCHEMICAL PHARMACOLOGY
    45. Rumjanek, VM; Trindade, GS; Wagner-Souza, K; Meletti-de-Oliveira, MC; Marques-Santos, LF; Maia, RC; Capella, MAM
      Multidrug resistance in tumour cells: characterisation of the multidrug resistant cell line K562-Lucena 1

      ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
    46. Hendrikse, NH
      Monitoring interactions at ATP-dependent drug efflux pumps

      CURRENT PHARMACEUTICAL DESIGN
    47. Kantharidis, P; El-Osta, S; de Silva, M; Lee, G; Hu, XF; Zalcberg, J
      Regulation of MDR1 gene expression: emerging concepts

      DRUG RESISTANCE UPDATES
    48. Filipits, M; Jaeger, U; Simonitsch, I; Chizzali-Bonfadin, C; Heinzl, H; Pirker, R
      Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas

      CLINICAL CANCER RESEARCH
    49. Tan, B; Piwnica-Worms, D; Ratner, L
      Multidrug resistance transporters and modulation

      CURRENT OPINION IN ONCOLOGY
    50. Bramwell, VHC
      Osteosarcomas and other cancers of bone

      CURRENT OPINION IN ONCOLOGY
    51. Oda, Y; Matsumoto, Y; Harimaya, K; Iwamoto, Y; Tsuneyoshi, M
      Establishment of new multidrug-resistant human osteosarcoma cell lines

      ONCOLOGY REPORTS
    52. Licht, T; Goldenberg, SK; Vieira, WD; Gottesman, MM; Pastan, I
      Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice

      GENE THERAPY
    53. Sonneveld, P
      Multidrug resistance in haematological malignancies

      JOURNAL OF INTERNAL MEDICINE
    54. van den Heuvel-Eibrink, MM; Sonneveld, P; Pieters, R
      The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    55. Motoji, T; Motomura, S; Wang, YH
      Multidrug resistance of acute leukemia and a strategy to overcome it

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    56. Norgaard, JM; Hokland, P
      Biology of multiple drug resistance in acute leukemia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    57. Belpomme, D; Gauthier, S; Pujade-Lauraine, E; Facchini, T; Goudier, MJ; Krakowski, I; Netter-Pinon, G; Frenay, M; Gousset, C; Marie, FN; Benmiloud, M; Sturtz, F
      Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma

      ANNALS OF ONCOLOGY
    58. Komori, T; Narabayashi, I; Matsui, R; Sueyoshi, K; Aratani, T; Utsunomiya, K
      Technetium-99m MIBI single photon emission computed tomography as an indicator of prognosis for patients with lung cancer - Preliminaly report

      ANNALS OF NUCLEAR MEDICINE
    59. Belaud-Rotureau, MA; Durrieu, F; Labroille, G; Lacombe, F; Fitoussi, O; Agape, P; Marit, G; Reiffers, J; Belloc, F
      Study of apoptosis-related responses of leukemic blast cells to in vitro anthracycline treatment

      LEUKEMIA
    60. Ross, DD
      Novel mechanisms of drug resistance in leukemia

      LEUKEMIA
    61. Solary, E; Mannone, L; Moreau, D; Caillot, D; Casasnovas, RO; Guy, H; Grandjean, M; Wolf, JE; Andre, F; Fenaux, P; Canal, P; Chauffert, B; Wotawa, A; Bayssas, M; Gennes, P
      Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes

      LEUKEMIA
    62. Filipits, M; Stranzl, T; Pohl, G; Heinzl, H; Jager, U; Geissler, K; Fonatsch, C; Haas, OA; Lechner, K; Pirker, R
      Drug resistance factors in acute myeloid leukemia: a comparative analysis

      LEUKEMIA
    63. Lu, Z; Kleeff, J; Shrikhande, S; Zimmermann, A; Korc, M; Friess, H; Buchler, MW
      Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer

      PANCREAS
    64. Becquemont, L; Camus, M; Kriaa, F; Barbu, V; Charpentier, B; Jaillon, P
      Low levels of lymphocyte MDR1 gene expression during early renal transplantation in patients treated with tacrolimus

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    65. Trammell, RA; Johnson, CB; Barker, JR; Bell, RS; Allan, DG
      Multidrug resistance-1 gene expression does not increase during tumor progression in the MGH-OGS murine osteosarcoma tumor model

      JOURNAL OF ORTHOPAEDIC RESEARCH
    66. Dahl, GV; Lacayo, NJ; Brophy, N; Dunussi-Joannopoulos, K; Weinstein, HJ; Chang, MR; Sikic, BI; Arceci, RJ
      Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    67. Gutierrez, M; Chabner, BA; Pearson, D; Steinberg, SM; Jaffe, ES; Cheson, BD; Fojo, A; Wilson, WH
      Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: An 8-year follow-up study of EPOCH

      JOURNAL OF CLINICAL ONCOLOGY
    68. Patnaik, A; Warner, E; Michael, M; Egorin, MJ; Moore, MJ; Siu, LL; Fracasso, PM; Rivkin, S; Kerr, I; Litchman, M; Oza, AM
      Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors

      JOURNAL OF CLINICAL ONCOLOGY
    69. Plaat, BEC; Hollema, H; Molenaar, WM; Broers, GHT; Piipe, J; Mastik, MF; Hoekstra, HJ; van den Berg, E; Scheper, RJ; van der Graaf, WTA
      Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors:Differences in clinical outcome and expression of multidrug resistance proteins

      JOURNAL OF CLINICAL ONCOLOGY
    70. Wunder, JS; Bull, SB; Aneliunas, V; Lee, PD; Davis, AM; Beauchamp, CP; Conrad, EU; Grimer, RJ; Healey, JH; Rock, MJ; Bell, RS; Andrulis, IL
      MDR1 gene expression and outcome in osteosarcoma: A prospective, multicenter study

      JOURNAL OF CLINICAL ONCOLOGY
    71. Wuchter, C; Karawajew, L; Ruppert, V; Schrappe, M; Buchner, T; Schoch, C; Haferlach, T; Harbott, JN; Ratei, R; Dorken, B; Ludwig, WD
      Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia

      HAEMATOLOGICA
    72. Vanhoefer, U; Achterrath, W; Wilke, H; Seeber, S
      Preclinical evaluation of irinotecan

      ONKOLOGIE
    73. Bart, J; Groen, HJM; Hendrikse, NH; van der Graaf, WTA; Vaalburg, W; de Vries, EGE
      The blood-brain barrier and oncology: new insights into function and modulation

      CANCER TREATMENT REVIEWS
    74. Pawlak, W; Zolnierek, J; Sarosiek, T; Szczylik, C
      Antisense therapy in cancer

      CANCER TREATMENT REVIEWS
    75. Lecureur, V; Courtois, A; Payen, L; Verhnet, L; Guillouzo, A; Fardel, O
      Expression and regulation of hepatic drug and bile acid transporters

      TOXICOLOGY
    76. Elferink, RPJO; Groen, AK
      Mechanisms of biliary lipid secretion and their role in lipid homeostasis

      SEMINARS IN LIVER DISEASE
    77. Rosati, A; Decorti, G; Klugmann, FB; Candussio, L; Granzotto, M; Melato, M; Giraldi, T
      Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart

      ANTICANCER RESEARCH
    78. Lo Muzio, L; Staibano, S; Pannone, G; Mignogna, MD; Serpico, R; Rubini, C; Fioroni, M; Fanali, S; Piattelli, A
      The human multidrug resistance gene (MDR-1): Immunocytochemical detection of its expression in oral SCC

      ANTICANCER RESEARCH
    79. Schipper, DL; Wagenmans, MJM; Peters, WHM; Wils, JAJM; Wagener, DJT
      Glutathione S-transferases and iododeoxyuridine labelling index during chemotherapy of gastric cancer

      ANTICANCER RESEARCH
    80. Martin-Aragon, S; Mukherjee, SK; Taylor, BJ; Ivy, SP; Fu, CH; Ardi, VC; Avramis, VI
      Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs

      ANTICANCER RESEARCH
    81. van Zuylen, L; Nooter, K; Sparreboom, A; Verweij, J
      Development of multidrug-resistance convertors: sense or nonsense?

      INVESTIGATIONAL NEW DRUGS
    82. Cortes, J; Kantarjian, HM
      Promising approaches in acute leukemia

      INVESTIGATIONAL NEW DRUGS
    83. Arnal, M; Franco, N; Fargeot, P; Riedinger, JM; Brunet-Lecomte, P; Lizard-Nacol, S
      Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    84. Chauncey, TR; Rankin, C; Anderson, JE; Chen, IM; Kopecky, KJ; Godwin, JE; Kalaycio, ME; Moore, DF; Shurafa, MS; Petersdorf, SH; Kraut, EH; Leith, CP; Head, DR; Luthardt, FW; Willman, CL; Appelbaum, FR
      A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and theMDR modulator PSC 833: a Southwest Oncology Group study 9617

      LEUKEMIA RESEARCH
    85. Theis, JGW; Chan, HSL; Greenberg, ML; Malkin, D; Karaskov, V; Moncica, I; Koren, G; Doyle, J
      Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma

      MEDICAL AND PEDIATRIC ONCOLOGY
    86. Jongsma, APM; Riethorst, A; Lankelma, J; Dekker, H; Westerhoff, HV
      Evaluating limited specificity of drug pumps - Reduced relative resistancein human MDR phenotypes

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    87. Kolfschoten, GM; Hulscher, TM; Pinedo, HM; Boven, E
      Drug resistance features and S-phase fraction as possible determinants fordrug response in a panel of human ovarian cancer xenografts

      BRITISH JOURNAL OF CANCER
    88. Schiedlmeier, B; Kuhlcke, K; Eckert, HG; Baum, C; Zeller, WJ; Fruehauf, S
      Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice

      BLOOD
    89. Ogretmen, B; Safa, AR
      Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line

      BIOCHEMISTRY
    90. Kakihara, T; Tanaka, A; Watanabe, A; Yamamoto, K; Kanto, K; Kataoka, S; Ogawa, A; Asami, K; Uchiyama, M
      Expression of multidrug resistance-related genes does not contribute to risk factors in newly diagnosed childhood acute lymphoblastic leukemia

      PEDIATRICS INTERNATIONAL
    91. Zhang, AM; Ohshima, K; Sato, K; Kanda, M; Suzumiya, J; Shimazaki, K; Kawasaki, C; Kikuchi, M
      Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas

      PATHOLOGY INTERNATIONAL
    92. Del Vecchio, S; Ciarmiello, A; Salvatore, M
      Clinical imaging of multidrug resistance in cancer

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    93. Ramachandran, C; Melnick, SJ
      Multidrug resistance review in human tumors - Molecular diagnosis and clinical significance

      MOLECULAR DIAGNOSIS
    94. Filipits, M; Drach, J; Pohl, G; Schuster, J; Stranzl, T; Ackermann, J; Konigsberg, R; Kaufmann, H; Gisslinger, H; Huber, H; Ludwig, H; Pirker, R
      Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma

      CLINICAL CANCER RESEARCH
    95. Scism, JL; Laska, DA; Horn, JW; Gimple, JL; Pratt, SE; Shepard, RL; Dantzig, AH; Wrighton, SA
      Evaluation of an in vitro coculture model for the blood-brain barrier: Comparison of human umbilical vein endothelial cells (ECV304) and rat glioma cells (C6) from two commercial sources

      IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
    96. Hebert, MF; Lam, AY
      Diltiazem increases tacrolimus concentrations

      ANNALS OF PHARMACOTHERAPY
    97. McCoy, C; McGee, SB; Cornwell, MM
      The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter

      CELL GROWTH & DIFFERENTIATION
    98. Messinger, Y; Uckun, FM
      A critical risk-benefit assessment argues against the use of anthracyclines in induction regimens for newly diagnosed childhood acute lymphoblastic leukemia

      LEUKEMIA & LYMPHOMA
    99. Rimsza, LM; Campbell, K; Dalton, WS; Salmon, S; Willcox, G; Grogan, TM
      The major vault protein (MVP), a new multidrug resistance associated protein, is frequently expressed in multiple myeloma

      LEUKEMIA & LYMPHOMA
    100. Pilarski, LM; Mant, MJ; Belch, AR
      Drug resistance in multiple myeloma: Novel therapeutic targets within the malignant clone

      LEUKEMIA & LYMPHOMA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 12:16:27